Nra-Alendronate 70 mg (Alendronic Acid (Alendronate Sodium) TABLET) 70 MG

NRA-ALENDRONATE 70 MG tablets contain alendronic acid, a medication used to treat osteoporosis and improve bone density. This oral tablet helps maintain bone health and reduce fracture risk.

Strength

70 MG

Manufacturer / TM Owner

NORA PHARMA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

NRA-ALENDRONATE 70 MG is primarily used to treat osteoporosis in postmenopausal women and men, helping to increase bone mass and strength. It is also used to prevent bone fractures and manage conditions like Paget's disease of bone. Alendronate sodium works by slowing down the process of bone breakdown, promoting stronger bones.

Side Effects

Common effects of NRA-ALENDRONATE 70 MG may include stomach upset, heartburn, and muscle pain. Some users experience mild nausea or difficulty swallowing. These effects are generally mild and temporary, but persistent issues should be discussed with a healthcare provider.

Precautions & Warnings

NRA-ALENDRONATE 70 MG should be taken with a full glass of water while standing or sitting upright to avoid irritation. It is important to avoid lying down for at least 30 minutes after taking the tablet. Patients with low calcium levels, kidney problems, or difficulty swallowing should use this medication with caution.

Avoid Interactions

NRA-ALENDRONATE 70 MG may interact with certain medications, including antacids, aspirin, and other nonsteroidal anti-inflammatory drugs (NSAIDs). Alcohol consumption should be limited, as it can increase the risk of stomach irritation. Always consult a healthcare provider before combining medications.

Frequently Asked Questions

NRA-ALENDRONATE 70 MG is used to treat osteoporosis and improve bone density, helping to reduce the risk of fractures.

Take NRA-ALENDRONATE 70 MG tablets with a full glass of water while standing or sitting upright, and avoid lying down for at least 30 minutes afterward.

Common side effects may include stomach upset, heartburn, muscle pain, and mild nausea.

It is advisable to limit alcohol consumption while taking NRA-ALENDRONATE 70 MG, as it can increase the risk of stomach irritation.

Patients with low calcium levels, kidney problems, or difficulty swallowing should use NRA-ALENDRONATE 70 MG with caution.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.